Thursday, April 27, 2017

Oncogene - Table of Contents alert Volume 36 Issue 17

If you are unable to see the message below, click here to view.


Volume 36, Issue 17 (April 2017)

In this issue
Original Articles

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed



Extracellular region of epidermal growth factor receptor: a potential target for anti-EGFR drug discovery

A Dokala and S S Thakur

Oncogene 2017 36: 2337-2344; advance online publication, October 24, 2016; 10.1038/onc.2016.393

Abstract | Full Text

Original Articles


Metformin alters DNA methylation genome-wide via the H19/SAHH axis OPEN

T Zhong, Y Men, L Lu, T Geng, J Zhou, A Mitsuhashi, M Shozu, N J Maihle, G G Carmichael, H S Taylor and Y Huang

Oncogene 2017 36: 2345-2354; advance online publication, October 24, 2016; 10.1038/onc.2016.391

Abstract | Full Text

p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors

A Chiche, M Moumen, M Romagnoli, V Petit, H Lasla, P Jézéquel, P de la Grange, J Jonkers, M-A Deugnier, M A Glukhova and M M Faraldo

Oncogene 2017 36: 2355-2365; advance online publication, October 24, 2016; 10.1038/onc.2016.396

Abstract | Full Text

Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients

M Burgess, S Mapp, R Mazzieri, C Cheung, L Chambers, S R Mattarollo, P Mollee, D Gill and N A Saunders

Oncogene 2017 36: 2366-2376; advance online publication, October 17, 2016; 10.1038/onc.2016.387

Abstract | Full Text

TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway OPEN

X Su, M Napoli, H A Abbas, A Venkatanarayan, N H B Bui, C Coarfa, Y J Gi, F Kittrell, P H Gunaratne, D Medina, J M Rosen, F Behbod and E R Flores

Oncogene 2017 36: 2377-2393; advance online publication, November 21, 2016; 10.1038/onc.2016.388

Abstract | Full Text

HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer

V Bogoevska, G Wolters-Eisfeld, B T Hofmann, A T El Gammal, B Mercanoglu, F Gebauer, Y K Vashist, D Bogoevski, D Perez, N Gagliani, J R Izbicki, M Bockhorn and C Güngör

Oncogene 2017 36: 2394-2404; advance online publication, December 12, 2016; 10.1038/onc.2016.390

Abstract | Full Text

Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress

K Chroma, M Mistrik, P Moudry, J Gursky, M Liptay, R Strauss, Z Skrott, R Vrtel, J Bartkova, J Kramara and J Bartek

Oncogene 2017 36: 2405-2422; advance online publication, November 14, 2016; 10.1038/onc.2016.392

Abstract | Full Text

Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway

G R Sareddy, S Viswanadhapalli, P Surapaneni, T Suzuki, A Brenner and R K Vadlamudi

Oncogene 2017 36: 2423-2434; advance online publication, November 28, 2016; 10.1038/onc.2016.395

Abstract | Full Text

DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection

H Fan, Z Cui, H Zhang, S K Mani, A Diab, L Lefrancois, N Fares, P Merle and O Andrisani

Oncogene 2017 36: 2435-2445; advance online publication, October 31, 2016; 10.1038/onc.2016.399

Abstract | Full Text

CAMK2γ antagonizes mTORC1 activation during hepatocarcinogenesis

Z Meng, X Ma, J Du, X Wang, M He, Y Gu, J Zhang, W Han, Z Fang, X Gan, C Van Ness, X Fu, D E Schones, R Xu and W Huang

Oncogene 2017 36: 2446-2456; advance online publication, November 7, 2016; 10.1038/onc.2016.400

Abstract | Full Text

Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner OPEN

J-Y Guo, H-S Hsu, S-W Tyan, F-Y Li, J-Y Shew, W-H Lee and J-Y Chen

Oncogene 2017 36: 2457-2471; advance online publication, November 7, 2016; 10.1038/onc.2016.404

Abstract | Full Text



InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancer OPEN

N Dimitrova, A B Nagaraj, A Razi, S Singh, S Kamalakaran, N Banerjee, P Joseph, A Mankovich, P Mittal, A DiFeo and V Varadan

Oncogene 2017 36: 2472-2482; advance online publication, November 7, 2016; 10.1038/onc.2016.398

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: